These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

195 related items for PubMed ID: 20849206

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. 5-HT(2C) receptor agonists and the control of appetite.
    Halford JC, Harrold JA.
    Handb Exp Pharmacol; 2012; (209):349-56. PubMed ID: 22249823
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. A short history of the 5-HT2C receptor: from the choroid plexus to depression, obesity and addiction treatment.
    Palacios JM, Pazos A, Hoyer D.
    Psychopharmacology (Berl); 2017 May; 234(9-10):1395-1418. PubMed ID: 28265714
    [Abstract] [Full Text] [Related]

  • 9. Contributions of 5-HT(2C) receptors to multiple actions of central serotonin systems.
    Giorgetti M, Tecott LH.
    Eur J Pharmacol; 2004 Mar 19; 488(1-3):1-9. PubMed ID: 15044029
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Involvement of some subtypes of 5-HT2-receptors in affective behavior in female rats].
    Fedotova IuO, Ordian NE, Frolova HO, Soboliev VI.
    Fiziol Zh (1994); 2012 Mar 19; 58(6):75-80. PubMed ID: 23530416
    [Abstract] [Full Text] [Related]

  • 13. Agonists of the serotonin 5-HT2C receptor: preclinical and clinical progression in multiple diseases.
    Wacker DA, Miller KJ.
    Curr Opin Drug Discov Devel; 2008 Jul 19; 11(4):438-45. PubMed ID: 18600561
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Anxiolytic activity of a novel potent serotonin 5-HT2C receptor antagonist FR260010: a comparison with diazepam and buspirone.
    Harada K, Aota M, Inoue T, Matsuda R, Mihara T, Yamaji T, Ishibashi K, Matsuoka N.
    Eur J Pharmacol; 2006 Dec 28; 553(1-3):171-84. PubMed ID: 17074317
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Novel structural insights for drug design of selective 5-HT(2C) inverse agonists from a ligand-biased receptor model.
    Renault N, Gohier A, Chavatte P, Farce A.
    Eur J Med Chem; 2010 Nov 28; 45(11):5086-99. PubMed ID: 20880612
    [Abstract] [Full Text] [Related]

  • 18. We Need 2C but Not 2B: Developing Serotonin 2C (5-HT2C) Receptor Agonists for the Treatment of CNS Disorders.
    Cheng J, Kozikowski AP.
    ChemMedChem; 2015 Dec 28; 10(12):1963-7. PubMed ID: 26507582
    [Abstract] [Full Text] [Related]

  • 19. Modulation of dopamine release by striatal 5-HT2C receptors.
    Alex KD, Yavanian GJ, McFarlane HG, Pluto CP, Pehek EA.
    Synapse; 2005 Mar 15; 55(4):242-51. PubMed ID: 15668911
    [Abstract] [Full Text] [Related]

  • 20. Serotonin-2C receptor agonists decrease potassium-stimulated GABA release in the nucleus accumbens.
    Kasper JM, Booth RG, Peris J.
    Synapse; 2015 Feb 15; 69(2):78-85. PubMed ID: 25382408
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.